{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:14:47Z","timestamp":1791962087647,"version":"4.3.4"},"reference-count":105,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Pediatric acute lymphoblastic leukemia (ALL) has achieved close to 90% cure rates through extensive collaborative and integrative molecular research, clinical studies, and advances in supportive care. Despite this high achievement, venous thromboembolic complications (VTE) remain one of the most common and potentially preventable therapy-associated adverse events in ALL. The majority of thromboses events involve the upper central venous system which is related to the use and location of central venous catheters (CVC). The reported rates of symptomatic and asymptomatic CVC-related VTE range from 2.6 to 36.7% and 5.9 to 43%, respectively. Thrombosis can negatively impact not only disease-free survival [e.g., therapy delays and\/or interruption, omission of chemotherapy agents (e.g., asparaginase therapy)] but also can result in long-term adverse effects that can impair the quality of life of ALL survivors (e.g., post-thrombotic syndrome, central nervous system (CNS)-thrombosis related complications: seizures, neurocognitive deficits). In this review, will discuss thrombosis pathophysiology in pediatric ALL, risk factors, treatment, and prevention strategies. In addition, the recently published clinical efficacy and safety of direct oral anticoagulants (DOACs) use in thrombosis treatment, and their potential role in primary\/secondary thrombosis prevention in pediatric patients with ALL will be discussed. Future clinical trials involving the use of these novel oral anticoagulants should be studied in ALL not only for primary thrombosis prevention but also in the treatment of thrombosis and its secondary prevention. These future research findings could potentially extrapolate to VTE prevention strategies in other pediatric cancer diagnoses and children considered at high risk for VTE.<\/jats:p>","DOI":"10.3389\/fped.2022.828702","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T06:54:31Z","timestamp":1646895271000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Thrombosis Complications in Pediatric Acute Lymphoblastic Leukemia: Risk Factors, Management, and Prevention: Is There Any Role for Pharmacologic Prophylaxis?"],"prefix":"10.3389","volume":"10","author":[{"given":"Vilmarie","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.thromres.2003.10.013","article-title":"Thrombosis in children with acute lymphoblastic leukemia: part I. Epidemiology of thrombosis in children with acute lymphoblastic leukemia","volume":"111","author":"Athale","year":"2003","journal-title":"Thromb Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1182\/blood.V83.5.1251.1251","article-title":"Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE","volume":"83","author":"Andrew","year":"1994","journal-title":"Blood."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1542\/peds.2009-0768","article-title":"Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007","volume":"124","author":"Raffini","year":"2009","journal-title":"Pediatrics."},{"key":"B4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1067\/mpd.2001.118192","article-title":"Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands","volume":"139","author":"van Ommen","year":"2001","journal-title":"J Pediatr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e812","DOI":"10.1542\/peds.2012-0267","article-title":"Trends in venous thromboembolism-related hospitalizations, 1994-2009","volume":"130","author":"Boulet","year":"2012","journal-title":"Pediatrics."},{"key":"B6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.thromres.2013.12.021","article-title":"Venous thromboembolism in children with cancer-a population-based cohort study","volume":"133","author":"Walker","year":"2014","journal-title":"Thromb Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","article-title":"Childhood acute lymphoblastic leukemia: progress through collaboration","volume":"33","author":"Pui","year":"2015","journal-title":"J Clin Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1160\/TH17-02-0109","article-title":"Increasing incidence and recurrence rate of venous thromboembolism in paediatric oncology patients in one single centre over 25 years","volume":"117","author":"Klaassen","year":"2017","journal-title":"Thromb Haemost."},{"key":"B9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1600-0609.1992.tb00032.x","article-title":"Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study. The GIMEMA group","volume":"49","author":"Gugliotta","year":"1992","journal-title":"Eur J Haematol."},{"key":"B10","first-page":"400","article-title":"Thrombosis in children receiving L-asparaginase. Determining patients at risk","volume":"15","author":"Shapiro","year":"1993","journal-title":"Am J Pediatr Hematol Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1055\/s-2008-1046625","article-title":"Increased thrombin generation during fibrinogen and platelet recovery as an explanation for hypercoagulability in children with L-asparaginase therapy for ALL or NHL: a preliminary report","volume":"206","author":"Korte","year":"1994","journal-title":"Klin Padiatr."},{"key":"B12","first-page":"120","article-title":"Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia","volume":"16","author":"Mitchell","year":"1994","journal-title":"Am J Pediatr Hematol Oncol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-2008-1043788","article-title":"Bleeding and thrombosis in children with acute lymphoblastic leukaemia, treated according to the ALL-BFM-90 protocol","volume":"211","author":"Sutor","year":"1999","journal-title":"Klin Padiatr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1007\/PL00014341","article-title":"Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters","volume":"158","author":"Wermes","year":"1999","journal-title":"Eur J Pediatr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1055\/s-0037-1613930","article-title":"Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols)","volume":"83","author":"Mauz-K\u00f6rholz","year":"2000","journal-title":"Thromb Haemost."},{"key":"B16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0049-3848(01)00286-9","article-title":"Thrombotic events revisited in children with acute lymphoblastic leukemia: impact of concomitant Escherichia coli asparaginase\/prednisone administration","volume":"103","author":"Nowak-G\u00f6ttl","year":"2001","journal-title":"Thromb Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1182\/blood.V97.5.1211","article-title":"Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01","volume":"97","author":"Silverman","year":"2001","journal-title":"Blood."},{"key":"B18","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1365-2141.2007.06677.x","article-title":"Thrombosis and acute lymphoblastic leukaemia","volume":"138","author":"Payne","year":"2007","journal-title":"Br J Haematol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1182\/blood-2006-04-015511","article-title":"Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients","volume":"108","author":"Caruso","year":"2006","journal-title":"Blood."},{"key":"B20","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/cncr.11042","article-title":"A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the prophylactic antithrombin replacement in kids with acute lymphoblastic leukemia treated with asparaginase (PARKAA) study","volume":"97","author":"Mitchell","year":"2003","journal-title":"Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1067\/mpd.2001.111272","article-title":"Catheter-related thrombosis in children with cancer","volume":"138","author":"Glaser","year":"2001","journal-title":"J Pediatr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/pbc.26036","article-title":"Prevalence of symptomatic and asymptomatic thrombosis in pediatric oncology patients with tunneled central venous catheters","volume":"63","author":"Schoot","year":"2016","journal-title":"Pediatr Blood Cancer."},{"key":"B23","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1182\/blood.V83.2.386.386","article-title":"Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiency","volume":"83","author":"Mitchell","year":"1994","journal-title":"Blood."},{"key":"B24","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/S0049-3848(20)30392-3","article-title":"Cancer-associated thrombosis in pediatric patients","volume":"191","author":"Barg","year":"2020","journal-title":"Thromb Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1055\/s-2007-976177","article-title":"Thromboembolic complications in pediatric hematologic malignancies","volume":"33","author":"Athale","year":"2007","journal-title":"Semin Thromb Hemost."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1158\/1078-0432.CCR-0734-04","article-title":"The effects of standard anthracycline-based chemotherapy on soluble ICAM-1 and vascular endothelial growth factor levels in breast cancer","volume":"10","author":"Mills","year":"2004","journal-title":"Clin Cancer Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0049-3848(00)00294-2","article-title":"Cisplatin triggers platelet activation","volume":"99","author":"Togna","year":"2000","journal-title":"Thromb Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1046\/j.1365-2141.2001.03095.x","article-title":"Thrombogenic role of cells undergoing apoptosis","volume":"115","author":"Wang","year":"2001","journal-title":"Br J Haematol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"V215","DOI":"10.1016\/S0049-3848(01)00285-7","article-title":"Molecular basis for the relationship between thrombosis and cancer","volume":"102","author":"Rickles","year":"2001","journal-title":"Thromb Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ajh.10263","article-title":"Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment","volume":"72","author":"Sutherland","year":"2003","journal-title":"Am J Hematol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0145-2126(00)00017-5","article-title":"Insight into the mechanism of asparaginase-induced depletion of antithrombin III in treatment of childhood acute lymphoblastic leukemia","volume":"24","author":"Bushman","year":"2000","journal-title":"Leuk Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1055\/s-2007-1000660","article-title":"Hemostasis in childhood acute lymphoblastic leukemia: coagulopathy induced by disease and treatment","volume":"21","author":"Mitchell","year":"1995","journal-title":"Semin Thromb Hemost."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1200\/JCO.1985.3.9.1266","article-title":"Altered von Willebrand factor molecule in children with thrombosis following asparaginase-prednisone-vincristine therapy for leukemia","volume":"3","author":"Pui","year":"1985","journal-title":"J Clin Oncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1055\/s-0038-1651179","article-title":"Evidence of a hypercoagulable state in patients with acute lymphoblastic leukemia treated with low dose of E. coli L-asparaginase: a GIMEMA study","volume":"69","author":"Leone","year":"1993","journal-title":"Thromb Haemost."},{"key":"B35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1600-0609.1995.tb00699.x","article-title":"Effects of Erwinia-asparaginase on the coagulation system","volume":"55","author":"Carlsson","year":"1995","journal-title":"Eur J Haematol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1600-0609.1996.tb00290.x","article-title":"Inhibition of hypercoagulation by antithrombin substitution in E coli L-asparaginase-treated children","volume":"56","author":"Nowak-G\u00f6ttl","year":"1996","journal-title":"Eur J Haematol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"F163","DOI":"10.1136\/fn.76.3.F163","article-title":"Neonatal symptomatic thromboembolism in Germany: two year survey","volume":"76","author":"Nowak-G\u00f6ttl","year":"1997","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"B38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/01.mbc.0000214709.11492.ec","article-title":"Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases","volume":"17","author":"Appel","year":"2006","journal-title":"Blood Coagul Fibrinolysis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/1951214a0","article-title":"Effects of corticosteroids on coagulation of the blood","volume":"195","author":"Ozsoylu","year":"1962","journal-title":"Nature."},{"key":"B40","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1600-0609.1970.tb01890.x","article-title":"Effect of prednisolone on the coagulation and fibrinolytic systems","volume":"7","author":"Isacson","year":"1970","journal-title":"Scand J Haematol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1055\/s-0038-1657142","article-title":"Increased factor VIII associated activities in Cushing's syndrome: a probable hypercoagulable state","volume":"47","author":"Dal Bo Zanon","year":"1982","journal-title":"Thromb Haemost."},{"key":"B42","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1159\/000186178","article-title":"Effect of corticosteroids on some hemostatic parameters in children with minimal change nephrotic syndrome","volume":"56","author":"Ueda","year":"1990","journal-title":"Nephron."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1097\/00007890-199505270-00010","article-title":"Reduced fibrinolytic potential one year after kidney transplantation. Relationship to long-term steroid treatment","volume":"59","author":"Patrassi","year":"1995","journal-title":"Transplantation."},{"key":"B44","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1055\/s-2008-1043789","article-title":"Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia","volume":"211","author":"Mall","year":"1999","journal-title":"Klin Padiatr."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1182\/blood-2002-06-1901","article-title":"Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration","volume":"101","author":"Nowak-G\u00f6ttl","year":"2003","journal-title":"Blood."},{"key":"B46","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1365-2141.2005.05528.x","article-title":"Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease","volume":"129","author":"Athale","year":"2005","journal-title":"Br J Haematol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1182\/blood-2018-01-827949","article-title":"Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years","volume":"131","author":"Rank","year":"2018","journal-title":"Blood."},{"key":"B48","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0022-3476(96)70338-4","article-title":"Right atrial thrombi in children with cancer and indwelling catheters","volume":"128","author":"Korones","year":"1996","journal-title":"J Pediatr."},{"key":"B49","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1182\/blood-2002-09-2731","article-title":"Central venous line-related thrombosis in children: association with central venous line location and insertion technique","volume":"101","author":"Male","year":"2003","journal-title":"Blood."},{"key":"B50","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/S0022-3476(98)70149-0","article-title":"Central venous catheter related thrombosis in children: analysis of the Canadian registry of venous thromboembolic complications","volume":"133","author":"Massicotte","year":"1998","journal-title":"J Pediatr."},{"key":"B51","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1538-7836.2010.04126.x","article-title":"Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies","volume":"9","author":"Saber","year":"2011","journal-title":"J Thromb Haemost."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1200\/JCO.2005.12.097","article-title":"Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement","volume":"23","author":"McLean","year":"2005","journal-title":"J Clin Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.jpeds.2013.06.076","article-title":"Port-a-cath-related thrombosis and postthrombotic syndrome in pediatric oncology patients","volume":"163","author":"Albisetti","year":"2013","journal-title":"J Pediatr."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1182\/blood.V93.5.1595","article-title":"Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors","volume":"93","author":"Nowak-G\u00f6ttl","year":"1999","journal-title":"Blood."},{"key":"B55","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/bjh.15752","article-title":"Thrombophilia screening and thromboprophylaxis may benefit specific ethnic subgroups with paediatric acute lymphoblastic leukaemia","volume":"184","author":"Barzilai-Birenboim","year":"2019","journal-title":"Br J Haematol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jama.2014.732","article-title":"Prevalence of obesity among adults and youth: United States, 2011-2014","author":"Ogden","year":"2015","journal-title":"NCHS Data Brief"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1046\/j.1538-7836.2003.00279.x","article-title":"Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk","volume":"1","author":"Juhan-Vague","year":"2003","journal-title":"J Thromb Haemost."},{"key":"B58","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1046\/j.1467-789X.2002.00056.x","article-title":"Obesity, haemostasis and the fibrinolytic system","volume":"3","author":"Mertens","year":"2002","journal-title":"Obes Rev."},{"key":"B59","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.thromres.2018.02.150","article-title":"Obesity and risk for venous thromboembolism from contemporary therapy for pediatric acute lymphoblastic leukemia","volume":"165","author":"Prasca","year":"2018","journal-title":"Thromb Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/rth2.12182","article-title":"Venous thromboembolism in a large cohort of children with acute lymphoblastic leukemia: risk factors and effect on prognosis","volume":"3","author":"Klaassen","year":"2019","journal-title":"Res Pract Thromb Haemost."},{"key":"B61","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/bjh.14048","article-title":"Incidence and risk factors for Central Nervous System thrombosis in paediatric acute lymphoblastic leukaemia during intensive asparaginase treatment: a single-centre cohort study","volume":"174","author":"Duarte","year":"2016","journal-title":"Br J Haematol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/bjh.14231","article-title":"Cerebral sinovenous thrombosis in children and young adults with acute lymphoblastic leukaemia-a cohort study from the United Kingdom","volume":"179","author":"Musgrave","year":"2017","journal-title":"Br J Haematol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/bjh.13162","article-title":"Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia-a multicentre study from the Nordic Society of Paediatric Haematology and Oncology","volume":"168","author":"Ranta","year":"2015","journal-title":"Br J Haematol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1365-2141.2010.08132.x","article-title":"Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safe","volume":"149","author":"Qureshi","year":"2010","journal-title":"Br J Haematol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.pediatrneurol.2013.04.009","article-title":"Hemorrhagic and ischemic stroke in children with cancer","volume":"49","author":"Noje","year":"2013","journal-title":"Pediatr Neurol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pbc.26694","article-title":"Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: risk factors and management","volume":"64","author":"Ghanem","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"B67","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/01.mph.0000157379.44167.b5","article-title":"Ischemic stroke in children treated for acute lymphoblastic leukemia: a retrospective study","volume":"27","author":"Santoro","year":"2005","journal-title":"J Pediatr Hematol Oncol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3109\/10428191003754608","article-title":"Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution","volume":"51","author":"Parasole","year":"2010","journal-title":"Leuk Lymphoma."},{"key":"B69","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/rth2.12356","article-title":"Pulmonary embolism in acute lymphoblastic leukemia\u2014An observational study of 1685 patients treated according to the NOPHO ALL2008 protocol","volume":"4","author":"Tuckuviene","year":"2020","journal-title":"Res Pract Thromb Haemost."},{"key":"B70","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1055\/s-2007-996089","article-title":"The natural history of deep-vein thrombosis","volume":"23","author":"Prandoni","year":"1997","journal-title":"Semin Thromb Hemost."},{"key":"B71","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.thromres.2003.09.008","article-title":"A cross-sectional study evaluating post-thrombotic syndrome in children","volume":"111","author":"Kuhle","year":"2003","journal-title":"Thromb Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.3324\/haematol.2010.026989","article-title":"Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors","volume":"95","author":"Goldenberg","year":"2010","journal-title":"Haematologica."},{"key":"B73","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0741-5214(95)70271-7","article-title":"Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one- to six-year follow-up","volume":"21","author":"Johnson","year":"1995","journal-title":"J Vasc Surg"},{"key":"B74","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1365-2796.1993.tb00707.x","article-title":"Deep vein thrombosis: a 7-year follow-up study","volume":"234","author":"Heldal","year":"1993","journal-title":"J Intern Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/pbc.25302","article-title":"Post-thrombotic syndrome after central venous catheter removal in childhood cancer survivors: a prospective cohort study","volume":"62","author":"Polen","year":"2015","journal-title":"Pediatr Blood Cancer."},{"key":"B76","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1200\/JCO.2005.05.5343","article-title":"Catheter-related deep venous thrombosis and other catheter complications in children with cancer","volume":"24","author":"Journeycake","year":"2006","journal-title":"J Clin Oncol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1538-7836.2008.02901.x","article-title":"Prevalence of post-thrombotic syndrome following asymptomatic thrombosis in survivors of acute lymphoblastic leukemia","volume":"6","author":"Kuhle","year":"2008","journal-title":"J Thromb Haemost."},{"key":"B78","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/ajh.26193","article-title":"Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: a report from CYP-C","volume":"96","author":"Pelland-Marcotte","year":"2021","journal-title":"Am J Hematol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1200\/JCO.19.03024","article-title":"Impact of asparaginase discontinuation on outcome in childhood acute lymphoblastic leukemia: a report from the children's oncology Group","volume":"38","author":"Gupta","year":"2020","journal-title":"J Clin Oncol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1365-2141.2010.08524.x","article-title":"The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols","volume":"152","author":"Grace","year":"2011","journal-title":"Br J Haematol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/brain\/awh412","article-title":"Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome","volume":"128","author":"S\u00e9bire","year":"2005","journal-title":"Brain."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/j.1469-8749.2010.03722.x","article-title":"Cerebral sinus venous thrombosis in Swiss children","volume":"52","author":"Grunt","year":"2010","journal-title":"Dev Med Child Neurol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/MPH.0b013e31827e8dbd","article-title":"Cerebral venous sinus thrombosis in pediatric cancer patients: long-term neurological outcomes","volume":"35","author":"Ross","year":"2013","journal-title":"J Pediatr Hematol Oncol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"e737S","DOI":"10.1378\/chest.11-2308","article-title":"Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Monagle","year":"2012","journal-title":"Chest."},{"key":"B85","doi-asserted-by":"publisher","first-page":"Cd008500","DOI":"10.1002\/14651858.CD008500.pub4","article-title":"Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy","volume":"12","author":"Di Nisio","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"B86","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/bjh.16695","article-title":"Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase-based therapy","volume":"191","author":"Sibai","year":"2020","journal-title":"Br J Haematol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","article-title":"Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)","volume":"36","author":"Young","year":"2018","journal-title":"J Clin Oncol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.thromres.2018.02.144","article-title":"Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): a systematic review and meta-analysis","volume":"173","author":"Li","year":"2019","journal-title":"Thromb Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3109\/08880018609031197","article-title":"Correction of hemostatic imbalances induced by L-asparaginase therapy in children with acute lymphoblastic leukemia","volume":"3","author":"Zaunschirm","year":"1986","journal-title":"Pediatr Hematol Oncol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0049-3848(03)00099-9","article-title":"An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial","volume":"109","author":"Massicotte","year":"2003","journal-title":"Thromb Res."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1080\/08035250600729092","article-title":"Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies\u2013a randomized, controlled study","volume":"95","author":"Ruud","year":"2006","journal-title":"Acta Paediatr."},{"key":"B92","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/00001721-200107000-00005","article-title":"Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia","volume":"12","author":"Elhasid","year":"2001","journal-title":"Blood Coagul Fibrinolysis."},{"key":"B93","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1055\/s-0041-1725944","article-title":"Efficacy and safety of non-vitamin K antagonist oral anticoagulants in pediatric venous thromboembolism treatment and thromboprophylaxis: a systematic review of the literature","volume":"47","author":"Branstetter","year":"2021","journal-title":"Semin Thromb Hemost."},{"key":"B94","doi-asserted-by":"publisher","first-page":"5146","DOI":"10.1182\/blood-2009-07-231084","article-title":"The impact of prophylactic fresh-frozen plasma and cryoprecipitate on the incidence of central nervous system thrombosis and hemorrhage in children with acute lymphoblastic leukemia receiving asparaginase","volume":"114","author":"Abbott","year":"2009","journal-title":"Blood."},{"key":"B95","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/10428190500052206","article-title":"Cerebral thrombotic complications in adolescent leukemia\/lymphoma patients treated with L-asparaginase-containing chemotherapy","volume":"46","author":"Imamura","year":"2005","journal-title":"Leuk Lymphoma."},{"key":"B96","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1046\/j.1442-200X.2002.01556.x","article-title":"Low plasma levels of hemostatic proteins during the induction phase in children with acute lymphoblastic leukemia: A retrospective study by the JACLS. Japan association of childhood leukemia study","volume":"44","author":"Hongo","year":"2002","journal-title":"Pediatr Int."},{"key":"B97","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/pbc.21222","article-title":"Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia","volume":"50","author":"Meister","year":"2008","journal-title":"Pediatr Blood Cancer."},{"key":"B98","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3324\/haematol.2018.194175","article-title":"THROMBOTECT-a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents","volume":"104","author":"Greiner","year":"2019","journal-title":"Haematologica."},{"key":"B99","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1055\/s-0039-1697027","article-title":"Effectiveness and safety of primary thromboprophylaxis in children with cancer: a systematic review of the literature and network meta-analysis","volume":"119","author":"Pelland-Marcotte","year":"2019","journal-title":"Thromb Haemost."},{"key":"B100","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S2352-3026(19)30219-4","article-title":"Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial","volume":"7","author":"Male","year":"2020","journal-title":"Lancet Haematol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.2139\/ssrn.3624247","article-title":"Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b\/3, non-inferiority trial","volume":"8","author":"Halton","year":"2021","journal-title":"Lancet Haematol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1182\/blood.2019000998","article-title":"Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children","volume":"135","author":"Brand\u00e3o","year":"2020","journal-title":"Blood."},{"key":"B103","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1055\/s-0039-1679938","article-title":"Apixaban compared to standard of care for prevention of venous thrombosis in paediatric acute lymphoblastic leukaemia (ALL)-rationale and design","volume":"119","author":"O'Brien","year":"2019","journal-title":"Thromb Haemost."},{"key":"B104","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.1182\/blood-2010-01-263012","article-title":"Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study","volume":"115","author":"Mitchell","year":"2010","journal-title":"Blood."},{"key":"B105","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3109\/08880018.2011.578705","article-title":"Thrombosis in children with acute lymphoblastic leukemia treated at a tertiary care center in Lebanon: revisiting the role of predictive models","volume":"28","author":"Al-Aridi","year":"2011","journal-title":"Pediatr Hematol Oncol."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.828702\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T06:54:37Z","timestamp":1646895277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.828702\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":105,"alternative-id":["10.3389\/fped.2022.828702"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.828702","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"article-number":"828702"}}